Terns Pharmaceuticals, Inc.
TERN
Cena:
$ 52.95
-0.02 (-0.04%)
Valuace
70
Růst
8
Zdraví
75
Zprávy
Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
TERNS PHARMACEUTICALS REPORTS INDUCEMENT GRANTS TO NEW EMPLOYEES UNDER NASDAQ LISTING RULE 5635(C)(4)
02-02-2026
FOSTER CITY, CALIF., FEB. 02, 2026 (GLOBE NEWSWIRE) -- TERNS PHARMACEUTICALS, INC. (“TERNS” OR T...
Více zde
TERNS PHARMACEUTICALS TO HIGHLIGHT 2026 PRIORITIES AND PROGRAM MILESTONES AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
07-01-2026
CARDINAL PHASE 1/2 TRIAL OF TERN-701 ENROLLING WELL, WITH MULTIPLE IMPORTANT MILESTONES IN 2026 PLAN...
Více zde
TERNS PHARMACEUTICALS REPORTS INDUCEMENT GRANTS TO NEW EMPLOYEES UNDER NASDAQ LISTING RULE 5635(C)(4)
02-01-2026
FOSTER CITY, CALIF., JAN. 02, 2026 (GLOBE NEWSWIRE) -- TERNS PHARMACEUTICALS, INC. (“TERNS” OR T...
Více zde
TERNS ANNOUNCES CLOSING OF PUBLIC OFFERING OF COMMON STOCK, INCLUDING FULL EXERCISE OF UNDERWRITERS' OPTION TO PURCHASE ADDITIONAL SHARES
11-12-2025
FOSTER CITY, CALIF., DEC. 11, 2025 (GLOBE NEWSWIRE) -- TERNS PHARMACEUTICALS, INC. (“TERNS” OR T...
Více zde
TERNS ANNOUNCES PRICING OF UPSIZED $650 MILLION PUBLIC OFFERING
09-12-2025
FOSTER CITY, CALIF., DEC. 09, 2025 (GLOBE NEWSWIRE) -- TERNS PHARMACEUTICALS, INC. (“TERNS” OR T...
Více zde
TERNS ANNOUNCES PROPOSED PUBLIC OFFERING
09-12-2025
FOSTER CITY, CALIF., DEC. 09, 2025 (GLOBE NEWSWIRE) -- TERNS PHARMACEUTICALS, INC. (“TERNS” OR T...
Více zde
TERNS HIGHLIGHTS ADDITIONAL POSITIVE PHASE 1 CLINICAL DATA SUPPORTING TERN-701'S BEST-IN-DISEASE POTENTIAL IN RELAPSED/REFRACTORY CML AT THE 67TH ASH ANNUAL MEETING
08-12-2025
64% MMR ACHIEVEMENT BY 24 WEEKS ACROSS ALL EFFICACY EVALUABLE PATIENTS 75% MMR ACHIEVEMENT BY 24 W...
Více zde
TERNS PHARMACEUTICALS TO PARTICIPATE IN THE JEFFERIES GLOBAL HEALTHCARE CONFERENCE IN LONDON
14-11-2025
FOSTER CITY, CALIF., NOV. 14, 2025 (GLOBE NEWSWIRE) -- TERNS PHARMACEUTICALS, INC. (“TERNS” OR T...
Více zde
TERNS PHARMACEUTICALS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATES
10-11-2025
UNPRECEDENTED PHASE 1 CML EFFICACY DATA AND POTENTIAL BEST-IN-DISEASE PROFILE OF TERN-701 FEATURED I...
Více zde
TERNS PHARMACEUTICALS REPORTS INDUCEMENT GRANTS TO NEW EMPLOYEES UNDER NASDAQ LISTING RULE 5635(C)(4)
04-11-2025
FOSTER CITY, CALIF., NOV. 04, 2025 (GLOBE NEWSWIRE) -- TERNS PHARMACEUTICALS, INC. (“TERNS” OR T...
Více zde
TERNS ANNOUNCES ABSTRACT WITH POSITIVE CLINICAL DATA FOR TERN-701 IN RELAPSED/REFRACTORY CML SELECTED FOR ORAL PRESENTATION AT 67TH ASH ANNUAL MEETING
03-11-2025
UNPRECEDENTED PHASE 1 CML EFFICACY DATA WITH 64% MMR ACHIEVEMENT BY 24 WEEKS IN A REFRACTORY PATIENT...
Více zde
TERNS PHARMACEUTICALS REPORTS TOPLINE 12-WEEK DATA FROM ITS PHASE 2 TRIAL EVALUATING ORAL GLP-1 RECEPTOR AGONIST TERN-601 IN OBESITY
21-10-2025
RESULTS SHOW MAXIMUM PLACEBO-ADJUSTED WEIGHT LOSS OF 4.6% WITH 12% TREATMENT DISCONTINUATION DUE TO ...
Více zde
TERNS PHARMACEUTICALS REPORTS INDUCEMENT GRANTS TO NEW EMPLOYEES UNDER NASDAQ LISTING RULE 5635(C)(4)
02-10-2025
FOSTER CITY, CALIF., OCT. 02, 2025 (GLOBE NEWSWIRE) -- TERNS PHARMACEUTICALS, INC. (“TERNS” OR T...
Více zde
TERNS PHARMACEUTICALS TO HOST AN EDUCATIONAL WEBINAR ON TERN-701 FOR INVESTORS IN ADVANCE OF PHASE 1 DATA EXPECTED IN FOURTH QUARTER 2025
21-08-2025
FOSTER CITY, CALIF., AUG. 21, 2025 (GLOBE NEWSWIRE) -- TERNS PHARMACEUTICALS, INC. (“TERNS” OR T...
Více zde
TERNS PHARMACEUTICALS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATES
05-08-2025
PHASE 1 TRIAL OF TERN-701 IN CHRONIC MYELOID LEUKEMIA (CML) ENROLLING WELL; EFFICACY AND SAFETY DATA...
Více zde
TERNS PHARMACEUTICALS REPORTS INDUCEMENT GRANTS TO NEW EMPLOYEES UNDER NASDAQ LISTING RULE 5635(C)(4)
04-08-2025
FOSTER CITY, CALIF., AUG. 04, 2025 (GLOBE NEWSWIRE) -- TERNS PHARMACEUTICALS, INC. (“TERNS” OR T...
Více zde
TERNS PHARMACEUTICALS PRESENTS POSITIVE DATA FROM PHASE 1 STUDY OF TERN-601 ONCE-DAILY ORAL GLP-1R AGONIST FOR TREATMENT OF OBESITY AT 85TH ANNUAL AMERICAN DIABETES ASSOCIATION SCIENTIFIC SESSIONS
23-06-2025
PHASE 1 CLINICAL STUDY OF TERN-601 DEMONSTRATED DIFFERENTIATED PROFILE IN 28-DAY STUDY; TOPLINE DATA...
Více zde
TERNS PHARMACEUTICALS TO PARTICIPATE IN UPCOMING JUNE INVESTOR CONFERENCES
29-05-2025
FOSTER CITY, CALIF., MAY 29, 2025 (GLOBE NEWSWIRE) -- TERNS PHARMACEUTICALS, INC. (“TERNS” OR TH...
Více zde
TERNS PHARMACEUTICALS SELECTED FOR ORAL PRESENTATION AT EUROPEAN HEMATOLOGY ASSOCIATION CONGRESS FOR PRECLINICAL DATA ON NOVEL ALLOSTERIC BCR-ABL INHIBITOR TERN-701
14-05-2025
PRECLINICAL DATA HIGHLIGHT IMPROVED POTENCY VS. ASCIMINIB ACROSS MULTIPLE CLINICALLY RELEVANT VARIAN...
Více zde
TERNS PHARMACEUTICALS REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATES
08-05-2025
INITIATED DOSE EXPANSION IN PHASE 1 CARDINAL TRIAL OF TERN-701 IN 2L+ CML ADDITIONAL SAFETY AND EFFI...
Více zde
TERNS PHARMACEUTICALS REPORTS INDUCEMENT GRANTS TO NEW EMPLOYEES UNDER NASDAQ LISTING RULE 5635(C)(4)
02-05-2025
FOSTER CITY, CALIF., MAY 02, 2025 (GLOBE NEWSWIRE) -- TERNS PHARMACEUTICALS, INC. (“TERNS” OR TH...
Více zde
TERNS PHARMACEUTICALS TO PARTICIPATE IN THE CITIZENS LIFE SCIENCES CONFERENCE
30-04-2025
FOSTER CITY, CALIF., APRIL 30, 2025 (GLOBE NEWSWIRE) -- TERNS PHARMACEUTICALS, INC. (“TERNS” OR ...
Více zde
TERNS PHARMACEUTICALS REPORTS INDUCEMENT GRANT TO NEW EMPLOYEES UNDER NASDAQ LISTING RULE 5635(C)(4)
02-04-2025
FOSTER CITY, CALIF., APRIL 02, 2025 (GLOBE NEWSWIRE) -- TERNS PHARMACEUTICALS, INC. (“TERNS” OR ...
Více zde
TERNS PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CORPORATE UPDATES
20-03-2025
DOSE EXPANSION IN PHASE 1 CARDINAL TRIAL OF TERN-701 FOR CHRONIC MYELOID LEUKEMIA (CML) EXPECTED TO ...
Více zde
TERNS PHARMACEUTICALS REPORTS INDUCEMENT GRANT TO NEW CHIEF FINANCIAL OFFICER UNDER NASDAQ LISTING RULE 5635(C)(4)
26-02-2025
FOSTER CITY, CALIF., FEB. 26, 2025 (GLOBE NEWSWIRE) -- TERNS PHARMACEUTICALS, INC. (“TERNS” OR T...
Více zde
TERNS PHARMACEUTICALS PROVIDES PROGRAM UPDATES AND ANNOUNCES PARTICIPATION AT TD COWEN 45TH ANNUAL HEALTHCARE CONFERENCE
25-02-2025
TERN-701 CARDINAL STUDY PROGRESSING WELL; DOSE EXPANSION EXPECTED TO INITIATE IN 2Q25 WITH ADDITIONA...
Více zde
TERNS PHARMACEUTICALS APPOINTS ANDREW GENGOS AS CHIEF FINANCIAL OFFICER
24-02-2025
SEASONED PUBLIC COMPANY CFO WITH 25 YEARS OF LEADERSHIP EXPERIENCE IN BIOTECH SEASONED PUBLIC COMPAN...
Více zde
TERNS PHARMACEUTICALS APPOINTS ROBERT AZELBY TO BOARD OF DIRECTORS
20-02-2025
SEASONED BIOTECHNOLOGY CEO BRINGS 25 YEARS OF STRATEGIC, OPERATIONAL AND COMMERCIAL EXPERTISE SEASON...
Více zde
TERNS PHARMACEUTICALS TO PARTICIPATE IN THE OPPENHEIMER 35TH ANNUAL HEALTHCARE LIFE SCIENCES CONFERENCE
05-02-2025
FOSTER CITY, CALIF., FEB. 05, 2025 (GLOBE NEWSWIRE) -- TERNS PHARMACEUTICALS, INC. (“TERNS” OR T...
Více zde
TERNS PHARMACEUTICALS REPORTS INDUCEMENT GRANT TO NEW EMPLOYEE UNDER NASDAQ LISTING RULE 5635(C)(4)
03-02-2025
FOSTER CITY, CALIF., FEB. 03, 2025 (GLOBE NEWSWIRE) -- TERNS PHARMACEUTICALS, INC. (“TERNS” OR T...
Více zde
| Datum | Typ | Otevřít EDGAR | Stáhnout dokument |
|---|---|---|---|
| 2026-01-22 00:00:00 | 8-K | Stáhnout | |
| 2026-01-09 00:00:00 | 8-K | Stáhnout | |
| 2025-12-11 00:00:00 | 8-K | Stáhnout | |
| 2025-12-08 00:00:00 | 8-K | Stáhnout | |
| 2025-11-10 00:00:00 | 8-K | Stáhnout | |
| 2025-11-10 00:00:00 | 10-Q | Stáhnout | |
| 2025-11-03 00:00:00 | 8-K | Stáhnout | |
| 2025-10-22 01:00:00 | 8-K | Stáhnout | |
| 2025-10-22 00:00:00 | 8-K | Stáhnout | |
| 2025-08-05 01:00:00 | 8-K | Stáhnout | |
| 2025-08-05 01:00:00 | 10-Q | Stáhnout | |
| 2025-08-05 00:00:00 | 8-K | Stáhnout | |
| 2025-08-05 00:00:00 | 10-Q | Stáhnout | |
| 2025-06-16 01:00:00 | 8-K | Stáhnout | |
| 2025-06-16 00:00:00 | 8-K | Stáhnout | |
| 2025-05-08 01:00:00 | 8-K | Stáhnout | |
| 2025-05-08 01:00:00 | 10-Q | Stáhnout | |
| 2025-05-08 00:00:00 | 8-K | Stáhnout | |
| 2025-05-08 00:00:00 | 10-Q | Stáhnout | |
| 2025-03-20 00:00:00 | 8-K | Stáhnout | |
| 2025-03-20 00:00:00 | 10-K | Stáhnout | |
| 2025-03-19 23:00:00 | 8-K | Stáhnout | |
| 2025-03-19 23:00:00 | 10-K | Stáhnout | |
| 2025-02-24 00:00:00 | 8-K | Stáhnout | |
| 2025-02-23 23:00:00 | 8-K | Stáhnout | |
| 2025-02-20 00:00:00 | 8-K | Stáhnout | |
| 2025-02-19 23:00:00 | 8-K | Stáhnout | |
| 2025-02-06 00:00:00 | 8-K | Stáhnout | |
| 2025-02-05 23:00:00 | 8-K | Stáhnout | |
| 2024-12-03 00:00:00 | 8-K | Stáhnout | |
| 2024-12-02 23:00:00 | 8-K | Stáhnout | |
| 2024-11-18 00:00:00 | 8-K | Stáhnout | |
| 2024-11-17 23:00:00 | 8-K | Stáhnout | |
| 2024-11-12 00:00:00 | 8-K | Stáhnout | |
| 2024-11-12 00:00:00 | 10-Q | Stáhnout | |
| 2024-11-11 23:00:00 | 8-K | Stáhnout | |
| 2024-11-11 23:00:00 | 10-Q | Stáhnout | |
| 2024-09-12 01:00:00 | 8-K | Stáhnout | |
| 2024-09-12 00:00:00 | 8-K | Stáhnout | |
| 2024-09-09 01:00:00 | 8-K | Stáhnout | |
| 2024-09-09 00:00:00 | 8-K | Stáhnout | |
| 2024-08-05 01:00:00 | 8-K | Stáhnout | |
| 2024-08-05 01:00:00 | 10-Q | Stáhnout | |
| 2024-08-05 00:00:00 | 8-K | Stáhnout | |
| 2024-08-05 00:00:00 | 10-Q | Stáhnout | |
| 2024-07-29 01:00:00 | 8-K | Stáhnout | |
| 2024-07-29 00:00:00 | 8-K | Stáhnout | |
| 2024-07-03 01:00:00 | 8-K | Stáhnout | |
| 2024-07-03 00:00:00 | 8-K | Stáhnout | |
| 2024-06-12 01:00:00 | 8-K | Stáhnout | |
| 2024-06-12 00:00:00 | 8-K | Stáhnout | |
| 2024-05-13 01:00:00 | 8-K | Stáhnout | |
| 2024-05-13 01:00:00 | 10-Q | Stáhnout | |
| 2024-05-13 00:00:00 | 8-K | Stáhnout | |
| 2024-05-13 00:00:00 | 10-Q | Stáhnout | |
| 2024-04-29 01:00:00 | 8-K | Stáhnout | |
| 2024-04-29 00:00:00 | 8-K | Stáhnout | |
| 2024-03-14 00:00:00 | 8-K | Stáhnout | |
| 2024-03-14 00:00:00 | 10-K | Stáhnout | |
| 2024-03-13 23:00:00 | 8-K | Stáhnout | |
| 2024-03-13 23:00:00 | 10-K | Stáhnout | |
| 2024-02-07 00:00:00 | 8-K | Stáhnout | |
| 2024-02-06 23:00:00 | 8-K | Stáhnout | |
| 2023-10-10 01:00:00 | 8-K | Stáhnout | |
| 2023-10-10 00:00:00 | 8-K | Stáhnout | |
| 2023-08-08 01:00:00 | 8-K | Stáhnout | |
| 2023-08-08 01:00:00 | 10-Q | Stáhnout | |
| 2023-08-08 00:00:00 | 8-K | Stáhnout | |
| 2023-08-08 00:00:00 | 10-Q | Stáhnout | |
| 2023-08-03 01:00:00 | 8-K | Stáhnout | |
| 2023-08-03 00:00:00 | 8-K | Stáhnout | |
| 2023-06-14 01:00:00 | 8-K | Stáhnout | |
| 2023-06-14 00:00:00 | 8-K | Stáhnout | |
| 2023-05-15 01:00:00 | 8-K | Stáhnout | |
| 2023-05-15 01:00:00 | 10-Q | Stáhnout | |
| 2023-05-15 00:00:00 | 8-K | Stáhnout | |
| 2023-05-15 00:00:00 | 10-Q | Stáhnout | |
| 2023-03-27 01:00:00 | 8-K | Stáhnout | |
| 2023-03-27 01:00:00 | 10-K | Stáhnout | |
| 2023-03-27 00:00:00 | 8-K | Stáhnout | |
| 2023-03-27 00:00:00 | 10-K | Stáhnout | |
| 2023-03-13 00:00:00 | 8-K | Stáhnout | |
| 2023-03-12 23:00:00 | 8-K | Stáhnout | |
| 2023-03-02 00:00:00 | 8-K | Stáhnout | |
| 2023-03-01 23:00:00 | 8-K | Stáhnout | |
| 2023-01-05 00:00:00 | 8-K | Stáhnout | |
| 2023-01-04 23:00:00 | 8-K | Stáhnout | |
| 2022-12-23 00:00:00 | 8-K | Stáhnout | |
| 2022-12-22 23:00:00 | 8-K | Stáhnout | |
| 2022-11-09 00:00:00 | 8-K | Stáhnout | |
| 2022-11-09 00:00:00 | 10-Q | Stáhnout | |
| 2022-11-08 23:00:00 | 8-K | Stáhnout | |
| 2022-11-08 23:00:00 | 10-Q | Stáhnout | |
| 2022-08-16 01:00:00 | 8-K | Stáhnout | |
| 2022-08-16 00:00:00 | 8-K | Stáhnout | |
| 2022-08-08 01:00:00 | 8-K | Stáhnout | |
| 2022-08-08 01:00:00 | 10-Q | Stáhnout | |
| 2022-08-08 00:00:00 | 8-K | Stáhnout | |
| 2022-08-08 00:00:00 | 10-Q | Stáhnout | |
| 2022-07-27 01:00:00 | 8-K | Stáhnout | |
| 2022-07-27 00:00:00 | 8-K | Stáhnout | |
| 2022-06-17 01:00:00 | 8-K | Stáhnout | |
| 2022-06-17 00:00:00 | 8-K | Stáhnout | |
| 2022-06-01 01:00:00 | 8-K | Stáhnout | |
| 2022-06-01 00:00:00 | 8-K | Stáhnout | |
| 2022-05-16 01:00:00 | 8-K | Stáhnout | |
| 2022-05-16 01:00:00 | 10-Q | Stáhnout | |
| 2022-05-16 00:00:00 | 8-K | Stáhnout | |
| 2022-05-16 00:00:00 | 10-Q | Stáhnout | |
| 2022-03-21 00:00:00 | 8-K | Stáhnout | |
| 2022-03-20 23:00:00 | 8-K | Stáhnout | |
| 2022-03-07 00:00:00 | 10-K | Stáhnout | |
| 2022-03-06 23:00:00 | 10-K | Stáhnout | |
| 2022-03-03 00:00:00 | 8-K | Stáhnout | |
| 2022-03-02 23:00:00 | 8-K | Stáhnout | |
| 2022-01-19 00:00:00 | 8-K | Stáhnout | |
| 2022-01-18 23:00:00 | 8-K | Stáhnout | |
| 2021-11-15 00:00:00 | 8-K | Stáhnout | |
| 2021-11-15 00:00:00 | 10-Q | Stáhnout | |
| 2021-11-14 23:00:00 | 8-K | Stáhnout | |
| 2021-11-14 23:00:00 | 10-Q | Stáhnout | |
| 2021-11-09 00:00:00 | 8-K | Stáhnout | |
| 2021-11-08 23:00:00 | 8-K | Stáhnout | |
| 2021-09-29 01:00:00 | 8-K | Stáhnout | |
| 2021-09-29 00:00:00 | 8-K | Stáhnout | |
| 2021-08-16 01:00:00 | 8-K | Stáhnout | |
| 2021-08-16 01:00:00 | 10-Q | Stáhnout | |
| 2021-08-16 00:00:00 | 8-K | Stáhnout | |
| 2021-08-16 00:00:00 | 10-Q | Stáhnout | |
| 2021-06-14 01:00:00 | 8-K | Stáhnout | |
| 2021-06-14 00:00:00 | 8-K | Stáhnout | |
| 2021-05-14 01:00:00 | 10-Q | Stáhnout | |
| 2021-05-14 00:00:00 | 10-Q | Stáhnout | |
| 2021-05-13 01:00:00 | 8-K | Stáhnout | |
| 2021-05-13 00:00:00 | 8-K | Stáhnout | |
| 2021-03-30 01:00:00 | 8-K | Stáhnout | |
| 2021-03-30 01:00:00 | 10-K | Stáhnout | |
| 2021-03-30 00:00:00 | 8-K | Stáhnout | |
| 2021-03-30 00:00:00 | 10-K | Stáhnout | |
| 2021-03-01 00:00:00 | 8-K | Stáhnout | |
| 2021-02-28 23:00:00 | 8-K | Stáhnout | |
| 2021-02-09 00:00:00 | 8-K | Stáhnout | |
| 2021-02-08 23:00:00 | 8-K | Stáhnout |
